Trial Profile

DELTA Study Dutch evaluation in liver transplantation to assess the efficacy of cyclosporine microemulsion with C2 monitoring versus tacrolimus with trough monitoring in de novo liver transplant recipients

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 23 Sep 2016

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Ciclosporin (Primary) ; Basiliximab; Methylprednisolone; Prednisone; Tacrolimus
Indications Liver transplant rejection
Focus Therapeutic Use
Acronyms DELTA
Sponsors Novartis

07 Sep 2011 Results presented at the 15th Congress of the European Society for Organ Transplantation.
11 Feb 2011 Actual end date (Dec 2007) added as reported by ClinicalTrials.gov.
11 Feb 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com